, Singapore
172 views

February 2022 trade grows by 21% YoY

Total exports increased to 22.3%, while total imports grew 19.6%.

Both exports and imports grew for the Lion City for February 2022, according to the latest data from Enterprise Singapore. 

Total exports increased by 22.3%, following the previous month's 22.1% growth. Total imports grew by 19.6%, following the 28.2% expansion in January 2022. On a seasonally-adjusted basis, the level of total trade reached $109b in February 2022, higher than the previous month's $108b.

The increase in external trade could be largely attributed to the 9.5% increase in non-oil domestic exports (NODX) in February, following the 17.6% expansion in the previous month. The growth was mainly due to non-electronics such as boat and ship structures, pharmaceuticals, and petrochemicals.

The NODX to the top 10 markets as a whole grew as follows in February 2022:

  • NODX to the EU 27 expanded by 53.7% in February 2022, after the 32.3% growth in January 2022, due to pharmaceuticals (+120.8%), specialised machinery (+56.8%) and electrical circuit apparatus (+216.2%). 
  • NODX to China grew by 19.2% in February 2022, following the 26.1% expansion in the preceding month, due to pharmaceuticals (+199.6%), petrochemicals (+14.2%) and measuring instruments (+59.4%).
  • NODX to Malaysia rose by 29.8% in February 2022, following the 20.1% growth in the preceding month, due to ICs (+136.3%), specialised machinery (+43.5%) and medical apparatus (+411.3%).

ING senior economist Nicholas Mapa said the slowdown in NODX can be traced to a contraction of shipments to the United States and slower exports to emerging markets and China. However, despite falling below market expectations, Mapa noted NODX growth extended its positive streak to 14 months.

"With the global growth outlook dimming over the past few weeks, we can expect trade activity to slow further, with NODX likewise expected to see more moderation in the coming months. Positive but slowing NODX expansion will likely sap some growth momentum, which will likely factor into our growth projections for the rest of the year," Mapa said. 

Meanwhile, UOB economist Barnabas Gan remains cautious over potential downside risks surrounding the ongoing geopolitical tensions. 

"Singapore’s direct trade exposure to Russia and Ukraine is likely negligible, although we are cognizant that second-order trade impact to Russia’s top trading partners, including China, Europe, US and Japan. We keep to our full-year NODX growth outlook of 2.0%, at the top-bound of Enterprise Singapore’s range forecast of 0.0% - 2.0% in 2022," Gan said. 

Follow the link s for more news on

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

If you've been wondering whether SBR could work for your company — yes, probably.

A lot of the companies we partner with started as readers. They'd been following our coverage for a while, saw their own customers and competitors in it, and eventually asked the obvious question: could we do something with you? The answer is usually yes. The shape of it depends on what you're trying to do.


The options are broader than most people assume — thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. Some partners use one channel; most use a mix. We figure out the right combination by starting with your brief, not with our rate card.


So if the question has been on your mind, here's the easy way to ask it.

We'll tell you honestly whether we can help, and how. It's a better use of everyone's time.

Top News

7 in 10 unprepared for AI-driven cyberattacks
Only 38% said their organisation provided training on how to use AI whilst avoiding exploitation.
CCS overhauls passenger airline alliance framework
Airline alliance notifications are now streamlined into a three-step approach.
Aviation
Raffles Medical net profit falls 9.6% to $29m in H1
Its healthcare services division posted a 16% drop in revenue to $119.5m.
Healthcare